# Magdent

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/magdent

- Industry: Medical Devices & Equipment
- Headquarters: Tiberias, Israel
- Website: www.magdentmed.com
- Total disclosed funding: $1.8M
- Latest round: Angel (Dec 4, 2017)
- Investors on record: 1

## About

Magdent Ltd. specializes in developing innovative electromagnetic healing abutments that accelerate the healing process for dental implants, enhancing patient outcomes with advanced technology.Founded in 2010 in Tiberias, Israel, Magdent Ltd. focuses on advancing dental implant technology through its electromagnetic healing abutments. The company raised USD 1.75 mn in an Angel round on December 4, 2017, led by Trendlines Group. Shlomo Barak is the founder, while Benny Barak serves as the CEO. Magdent has completed 2 deals to date.Magdent specializes in the development and provision of electromagnetic healing abutments designed to enhance the healing process associated with dental implants. Their core product leverages Pulsed Electromagnetic Field Therapy (PEMF) technology, which combines antimicrobial, anti-inflammatory, and regenerative properties, facilitating quicker recovery and improved success rates for dental implant procedures. The primary end users of these products include dental professionals, implant surgeons, and patients requiring dental implants, particularly those with challenging medical histories such as heavy smokers, diabetics, and oncology patients. Magdent's products are marketed primarily in Europe, with a focus on countries actively engaged in advanced dental implant technologies. The company aims to address critical issues in dental healthcare by reducing complications, accelerating healing times, and improving overall patient outcomes.Magdent generates revenue primarily through direct sales of its electromagnetic healing abutments to dental clinics and implant centers. The transaction structure involves a B2B model where dental professionals purchase these innovative products to enhance their service offerings and treatment outcomes. Pricing is structured to reflect the value added by the technology, with potential costs associated with the abutments reaching up to USD 300, depending on the treatment complexity and patient needs. Furthermore, the company offers its technology at no upfront cost to implant manufacturers, positioning it as a value-adding partner in the dental supply chain. This strategic approach not only fosters collaboration with implant companies but also enhances market penetration and encourages dentists to adopt these advanced solutions without significant capital investment.Following the Angel funding of USD 1.75 mn in December 2017, Magdent Ltd. plans to utilize these resources to expand its product offerings and enhance its market presence. The company is designing new electromagnetic abutments aimed at improving patient recovery times and enhancing treatment outcomes. Specific targets for market expansion include regions in Europe with a high demand for advanced dental implant technologies, expected to commence within the next two years. The recent funding will support the development of these new products and their introduction to new markets.

## Funding rounds

- Angel, Dec 4, 2017, $1.8M — Trendlines Group

## Investors

- Trendlines Group (https://capitalatlas.ai/funds/trendlines-group) — Angel